0001493152-18-003194.txt : 20180309
0001493152-18-003194.hdr.sgml : 20180309
20180309173246
ACCESSION NUMBER: 0001493152-18-003194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180307
FILED AS OF DATE: 20180309
DATE AS OF CHANGE: 20180309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STOVER JACK E
CENTRAL INDEX KEY: 0001203603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24249
FILM NUMBER: 18681279
MAIL ADDRESS:
STREET 1: C/O SICOR INC
STREET 2: 19 HUGHES
CITY: IRVINE
STATE: CA
ZIP: 92618-1902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Interpace Diagnostics Group, Inc.
CENTRAL INDEX KEY: 0001054102
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 222919486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 412-224-6100
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: PDI INC
DATE OF NAME CHANGE: 20021113
FORMER COMPANY:
FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC
DATE OF NAME CHANGE: 19980129
4
1
form4.xml
X0306
4
2018-03-07
0
0001054102
Interpace Diagnostics Group, Inc.
IDXG
0001203603
STOVER JACK E
C/O INTERPACE DIAGNOSTICS GROUP, INC.
300 INTERPACE PARKWAY
PARSIPPANY
NJ
07054
1
1
0
0
President and CEO
Common Stock
2018-03-07
4
A
0
56000
A
75738
D
Stock Option (right to buy)
1.01
2018-03-07
4
A
0
224000
0.00
A
2028-03-07
Common Stock
224000
224000
D
The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
Reflects 1-for-10 reverse stock split, effective as of December 28, 2016.
The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.
/s/ Jack E. Stover
2018-03-09